Aktie A1JLYP CHINA MEDICAL SYSTEM HOLDINGS LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen China Medical System Holdings Limited

Aktien

A1JLYP

KYG211081248

867

Markt geschlossen - Hong Kong S.E.
Andere Börsenplätze
 10:08:42 28.06.2024 		% 5 Tage % 1. Jan.
6.62 HKD -.--% Intraday Chart für China Medical System Holdings Limited -4.61% -52.17%
25.06. China Medical System Holdings Limited schließt Dosierung des ersten Probanden in der Phase-III-Überbrückungsstudie mit Ruxolitinib-Creme bei atopischer Dermatitis in China ab CI
18.06. China Medical System erhält Arzneimittelzulassungszertifikat für Medikament zur Visualisierung von Läsionen in China MT

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
China Medical System Completes Dosing of the First Subject in Phase III Bridging Trial of Ruxolitinib Cream in Atopic Dermatitis in China
China Medical System Holdings Limited Completes Dosing of the First Subject in Phase III Bridging Trial of Ruxolitinib Cream in Atopic Dermatitis in China
Cosmo's oral diagnostic drug Lumeblue receives approval of New Drug Application in China
Bourse Zurich: séance en manque d'impulsion en perspective
China Medical System Gets Drug Registration Certificate for Lesion Visualization Drug in China
China Medical System: Innovative Drug Methylthioninium Chloride Enteric-coated Sustained-release Tablets Approved for Marketing in China
China Medical System Holdings Limited Announces Approval of Lumeblue® by NMPA for Enhanced Colorectal Lesion Detection
China Medical System Holdings Limited Approves Final Dividend for the Year Ended 31 December 2023
China Medical System: New Drug Application of Desidustat Tablets Accepted in China
China Medical System's Anti-Anaemia NDA Accepted in China
China Medical System Holdings Limited Announces New Drug Application of Desidustat Tablets Accepted in China
Zydus Lifesciences' Desidustat Tablets Get Nod from China Regulator
China Medical System Registers New Vitiligo Drug in Macau
China Medical System Holdings Limited commences an Equity Buyback for 245,198,851 shares, representing 10% of its issued share capital, under the authorization approved on April 28, 2023.
Incyte, China Medical System Sign Collaboration, License Agreement
CMS and Incyte Announce Collaboration and License Agreement for Povorcitinib in China and Southeast Asia
Incyte Corporation and China Medical System Holdings Limited Announce Collaboration and License Agreement for Povorcitinib, an Oral Jak1 Inhibitor, in Mainland China, Hong Kong, Macau, Taiwan and Southeast Asia
China Medical System （867.HK）2023 Annual Results: Despite of the Temporary Financial Performance Pressure Fresh Catalysts Emerged from Successive Innovation Breakthroughs
China Medical System Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023
China Medical System Holdings Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on About 23 May 2024
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A1JLYP Aktie
  4. Nachrichten China Medical System Holdings Limited
  5. Andere Sprachen